GGrantIndex
Sort

50,496 grants matching lung cancer

Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model

$520,533
Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2014 · CA

Biodegradable, Biocompatible Pressure Sensitive Adhesives

$520,496
Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2023 · HL

Understanding EGF receptor activation by growth factors and oncogenic mutations

$520,420
Mark A. Lemmon · Yale University · R01 · FY2018 · CA

Molecular Landscape-based Innovative Therapies for Anaplastic Thyroid Carcinoma

$520,414
Antonio Di Cristofano · Sloan-Kettering Inst Can Research · P50 · FY2017 · CA

Okazaki fragment maturation: mutagenesis and cell survival

$520,411
Binghui Shen · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA

Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model

$520,335
Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2015 · CA

Genomic and functional approaches to characterize Chr1q gains in cancer

$520,332
Jason Sheltzer · Yale University · R01 · FY2025 · CA

Glycosylation Mutants of Mice and Animal Cells

$520,266
Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2009 · CA

Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood

$520,236
Abhijit Patel · Yale University · U01 · FY2018 · CA

Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells

$520,139
David Schrump · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Nutritional & Behavioral Cancer Prevention in a Multiethnic Population

$520,132
Gertraud Maskarinec · University Of Hawaii At Manoa · R25 · FY2012 · CA

Strategies to predict and overcome resistance to cancer immunotherapy

$520,119
Steven L Reiner · Columbia University Health Sciences · R01 · FY2024 · CA

The consequences of RB-loss

$520,092
Nicholas J Dyson · Massachusetts General Hospital · R01 · FY2016 · GM

Mechanism of Eukaryotic Environmental Mutagenesis

$520,089
Graham C Walker · Massachusetts Institute Of Technology · R35 · FY2020 · ES

Raman Molecular Imaging for Early Detection of Colon Cancer

$520,010
Christopher H Contag · Stanford University · R01 · FY2015 · CA

Chemoprevention of Early Pulmonary Lesions in Mice

$520,008
University Of Colorado Denver · R01 · FY2003 · CA

Deciphering the molecular control of intratumoral dendritic cells

$519,902
Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

Biomarkers of NNK in prediction of lung cancer development in smokers

$519,880
Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · CA

PET Imaging of KRAS2 Activation to Guide EGFR Targeting in Cancer Therapy

$519,862
Eric Wickstrom · Thomas Jefferson University · R01 · FY2013 · CA

Mechanisms of enhancer regulation in leukemia

$519,834
Iannis Aifantis · New York University School Of Medicine · R01 · FY2019 · CA

Loss of NF1 drives hormone dependent mammary carcinogenesis in a rat model with intact immune system

$519,825
Deeann Wallis-Schultz · University Of Alabama At Birmingham · R01 · FY2024 · CA

Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer Agent

$519,807
Seth J Field · Case Western Reserve University · R01 · FY2024 · CA

Identifying and exploiting therapeutic vulnerabilities of tumor-host interactions that drive bone-to-meninges breast cancer metastasis

$519,766
Dorothy A Sipkins · Duke University · R01 · FY2023 · CA

Utilizing Interaction to Identify Novel Genetic Factors for Nicotine Dependence

$519,705
Dana B Hancock · Research Triangle Institute · R01 · FY2014 · DA

Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer

$519,704
Noriyuki Kasahara · University Of California, San Francisco · R01 · FY2022 · CA